GGrantIndex
Sort

53,477 grants matching addiction

Interdisciplinary Center of Excellence for the Study of Pain and Sensory Function

$2,142,323
Ian D Meng · University Of New England · P20 · FY2019 · GM

Interdisciplinary Center of Excellence for the Study of Pain and Sensory Function

$2,142,323
Ian D Meng · University Of New England · P20 · FY2020 · GM

Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics

$2,141,943
Irene Cortes-Puch · Eicosis, Llc · UH3 · FY2024 · DA

TARGET ENGAGEMENT OF INVESTIGATIONAL AGENTS IN PSPP

$2,139,595
Afshin Ghavami · Psychogenics, Inc. · N01 · FY2023 · DA

Development, Evaluation and Translation of Robotic Apparel for Alleviating Low Back Pain

$2,138,911
Conor Walsh · Harvard University · UH3 · FY2021 · AR

Rat Genome Database

$2,135,569
Anne E. Kwitek · Medical College Of Wisconsin · R01 · FY2021 · HL

Scientific and Statistical Computing Core

$2,134,685
Robert Cox · National Institute Of Mental Health · ZIC · FY2019 · MH

Oklahoma Center for Microbiome Research

$2,132,840
Tyrrell Conway · Oklahoma State University Stillwater · P20 · FY2025 · GM

Rat Genome Database

$2,132,754
Anne E. Kwitek · Medical College Of Wisconsin · R01 · FY2020 · HL

Interdisciplinary Center of Excellence for the Study of Pain and Sensory Function

$2,131,283
Ian D Meng · University Of New England · P20 · FY2018 · GM

Center for Neural Circuits in Addiction

$2,128,432
Mark J Thomas · University Of Minnesota · P30 · FY2020 · DA

Characterization of neuronal ensembles activated during drug-induced behavior

$2,127,730
Bruce Hope · National Institute On Drug Abuse · ZIA · FY2019 · DA

Mouse models of stress disorders and addiction

$2,127,605
Andrew Holmes · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA

SPRINT: Signature for Pain Recovery IN Teens

$2,126,713
Laura E Simons · Stanford University · R33 · FY2023 · NS

Culturally Response Integrated Harm Reduction Services for Black and Latinx People Who use Drugs

$2,125,558
Ayana Jordan · New York University School Of Medicine · R01 · FY2022 · DA

Characterization of neuronal ensembles activated during drug-induced behavior

$2,125,364
Bruce Hope · National Institute On Drug Abuse · ZIA · FY2018 · DA

Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)

$2,124,233
Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2021 · AI

PF614 MPAR Abuse Deterrent opioid prodrug with overdose protection: Pre-Clinical Development and Phase 1 Clinical Trial

$2,123,989
Lynn Kirkpatrick · Ensysce Biosciences, Inc. · UG3 · FY2018 · DA

Partnering to Achieve Wellness for Native Americans through Indigenous Knowledge (PAWNIK)

$2,121,737
Elizabeth J D'amico · Rand Corporation · OT2 · FY2025 · DA

Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center

$2,120,889
Peter D. Friedmann · Baystate Medical Center, Inc. · UG1 · FY2021 · DA

Transgenic resources for neuroscience research

$2,119,618
James Pickel · National Institute Of Mental Health · ZIC · FY2012 · MH

Emory-MSSM-GSK-NIMH Collaborative Mood and Anxiety Disorders Initiative

$2,119,140
Helen S Mayberg · Emory University · U19 · FY2010 · MH

Prevention Research Center: Parenting Among Women Who Are Opioid Users

$2,118,343
Leslie Diane Leve · University Of Oregon · P50 · FY2022 · DA

Neurocircuitry Underlying DBS Effects in OCD: A Window Into Mechanisms of Action

$2,116,917
Suzanne N Haber · University Of Rochester · P50 · FY2010 · MH

Neurocircuitry Underlying DBS Effects in OCD: A Window Into Mechanisms of Action

$2,116,265
Suzanne N Haber · University Of Rochester · P50 · FY2009 · MH